Molecular complexes of alprazolam with carboxylic acids, boric acid, boronic acids, and phenols. evaluation of supramolecular heterosynthons mediated by a triazole ring

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 3743-3753

  Varughese, Sunil ^a   Azim, Yasser ^a,b   Desiraju, Gautam R ^a,b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF HYDERABAD   (India)

Author keywords

Alprazolam; Co crystal; Crystal engineering; Drugs; Pharmaceuticals; Triazole

Indexed keywords

ALPRAZOLAM; BORIC ACID; BORONIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; GAMMA RESORCYLIC ACID; PHENOL DERIVATIVE; TRIAZOLE;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG STRUCTURE; HYDROGEN BOND;

EID: 77956386581     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22117     Document Type: Article

References (38)

1. Bond AD. 2007. What is a co-crystal? CrystEngComm 9:833-834.
2. Byrn S, Pfeiffer R, Stephenson G, Grant DJW, Gleason WB. 1994. Solid-state pharmaceutical chemistry. Chem Mater 6:1148-1158.
3. Vishweshwar P, McMohan JA, Bis JA, Zaworotko MJ. 2006. Pharmaceutical co-crystals. J Pharm Sci 95:499-516 and references cited within.
4. Schultheiss N, Newman A. 2009. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des 9:2950-2967.
5. Bhatt PM, Azim Y, Thakur TS, Desiraju GR. 2009. Co-crystals of the anti-HIV drugs lamivudine and zidovudine. Cryst Growth Des 9:951-957.
6. Herrmann M, Förter-Barth U, Kröbe H, Kempa PB, Juez- Lorenzo MM, Doyle MJ. 2009. Co-crystallization and characterization of pharmaceutical ingredients. Part Part Syst Charact 26:151-156.
7. Stanton MK, Bak A. 2008. Physicochemical properties of pharmaceutical co-crystals: A case study of tenAMG517 co-crystals. Cryst Growth Des 8:3856-3862.
8. Jones W, Motherwell WDS, Trask AV. 2006. Pharmaceutical cocrystals: An emerging approach to physical property enhancement. MRS Bull 31:875-879. (Pubitemid 44826643)
9. Trask AV, Motherwell WDS, Jones W. 2005. Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration. Cryst Growth Des 5:1013-1021.
10. Good DJ, Rodríguez-Hornedo N. 2009. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des 9:2252-2264.
11. NcNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O'Donnell E, Park A. 2006. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res 23:1888-1897.
12. Karki S, Friščíc T, Fábián L, Laity PR, Day GM, Jones W. 2009. Improving mechanical properties of crystalline solids by cocrystal formation: New compressible forms of paracetamol. Adv Mater 21:3905-3909.
13. Desiraju GR. 1995. Supramolecular synthons in crystal engineering: A new organic synthesis. Angew Chem Int Ed 34:2311-2327.
14. Thalladi VR, Goud BS, Hoy VJ, Allen FH, Howard JAK, Desiraju GR. 1996. Supramolecular synthons in crystal engineering. Structure simplification, synthon robustness and supramolecular retrosynthesis. Chem Commun 401-402.
15. Nangia A, Desiraju GR. 1998. Supramolecular synthons and pattern recognition. Top Curr Chem 198:58-95.
16. Walsh RDB, Bradner MW, Fleishman S, Morales LA, Moulton B, Rodríguez-Hornedo N, Zaworotko MJ. 2003. Crystal engineering of the composition of pharmaceutical phases. Chem Commun 186-187. (Pubitemid 36138703)
17. Sarma B, Nath NK, Bhogala BR, Nangia A. 2009. Synthon competition and cooperation in molecular salts of hydroxybenzoic acids and aminopyridines. Cryst Growth Des 9:1546-1557.
18. Pedireddi VR, Arora KK. 2003. A rational study of crystal engineering of supramolecular sassemblies of 1,2,4,5-benzene-tetracarboxylic acid. J Org Chem 68:9177-9185.
19. Bucar D-K, Henry RF, Lou X, Duerst RW, MacGillivray LR, Zhang GGZ. 2009. Cocrystals of caffeine and hydroxybenzoic acids composed of multiple supramolecular heterosynthons: Screening via solution-mediated phase transformation and structural characterization. Cryst Growth Des 9:1932-1943.
20. Vishweshwar P, Nangia A, Lynch VM. 2003. Molecular complexes of homologous alkanedicarboxylic acids with isonicotinamide: X-ray crystal structures, hydrogen bond synthons, and melting point alternation. Cryst Growth Des 3:783-790.
21. Allen FH, Kennard O. 1993. 3D search and research using the Cambridge Structural Database. Chem Des Auto News 8:31-37.
22. Remenar JF, Morissette SL, Peterson ML, Moulton B, Mac- Phee JM, Guzmán HR, Almarsson Ö. 2003. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J Am Chem Soc 125:8456-8457. (Pubitemid 36858412)
23. Dawson GW, Jue SG, Brogden RN. 1984. Alprazolam. A review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs 27:132-147.
24. VonVoigtlander PF, Straw RN. 1985. Alprazolam: Review of pharmacological, pharmacokinetic, and clinical data. Drug Dev Res 6:1-12.
25. Sheldrick GM. 1994. SADABS: Siemens Area Detector Absorption Correction Program. University of Gottingen. Germany.
26. Sheldrick GM. 1998. SHELX97 programs for crystal structure analysis. Version 97-2.
27. Spek AL. 1990. PLATON Molecular Geometry Program. Acta Crystallogr A46:C34.
28. Aullón G, Bellamy D, Orpen AG, Brammer L, Bruton EA. 1998. Metal-bound chlorine often accepts hydrogen bonds. Chem Commun 653-654.
29. Banerjee R, Desiraju GR, Mondal R, Howard JAK. 2004. Organic chlorine as a hydrogen-bridge acceptor: Evidence for the existence of intramolecular O-H···Cl-C Interactions in some gem-alkynols. Chem Eur J 10:3373-3383.
30. Papadopoulos N, Avranas A. 1991. Dissociation of salicylic acid, 2,4-, 2,5-, and 2,6-dihydroxybenzoic acids in 1-propanol -water mixtures at 258C. J Solut Chem 20:293-300.
31. Thalladi VR, Weiss H-C, Bläser D, Boese R, Nangia A, Desiraju GR. 1998. C-H···F interactions in the crystal structures of some fluorobenzenes. J Am Chem Soc 120:8702-8710.
32. Refcode CIZQAD01. The details of the interactions present in the assembly are provided in the supplementary information.
33. 3-3T. Acta Crystallogr C59:i47-i49.
34. Pedireddi VR, SeethaLekshmi N. 2004. Boronic acids in the design and synthesis of supramolecular assemblies. Tetrahedron Lett 45:1903-1906. (Pubitemid 38220803)
35. Aakeröy CB, Desper J, Levin B. 2005. Crystal engineering gone awry and the emergence of the boronic acid-carboxylate synthon. CrystEngComm 7:102-107.
36. Pedireddi VR, Reddy DS, Goud BS, Craig DC, Rae AD, Desiraju GR. 1994. The nature of halogen···halogen interactions and the crystal structure of 1,3,5,7-tetraiodoadamantane. J Chem Soc Perkin Trans 2:2353-2360.
37. Nangia A, Desiraju GR. 1999. Pseudopolymorphism: Occurences of hydrogen bonding organic solvents in molecular crystals. Chem Commun 605-606. (Pubitemid 29158703)
38. SPARC online calculator. http://sparc.chem.uga.edu/sparc/.